Launched in 2005, NAF’s biennial Ataxia Investigators Meeting (AIM) brings together world-leading Ataxia clinicians and scientists who are working to accelerate the pace of Ataxia research, better understand the disease, and develop therapies.
Due to the novel coronavirus COVID-19, NAF made the difficult, but necessary, decision to cancel the March 2020 Ataxia Investigators Meeting (AIM).
The meeting chair, Dr. Al La Spada at Duke University with the AIM Steering Committee members made the decision to reschedule the AIM 2020 to a virtual format. The rescheduled AIM will take place May 24-27, 2021.
The AIM agenda and program that was planned will be followed, as much as possible.
This meeting will address 5 themes:
Information about submission of abstracts for late-breaking news will be available in early January. Meeting registration information will be posted in January.
AIM Registration fees will be:
Sponsorship opportunities are available which will provide visibility, access and recognition. Industry sponsors will be offered complimentary registration based on the sponsorship level. For more information about sponsorship, contact Joel Sutherland, NAF’s Director of Development, at email@example.com.